Axq Capital, LP Annexon, Inc. Transaction History
Axq Capital, LP
- $417 Billion
- Q1 2024
A detailed history of Axq Capital, LP transactions in Annexon, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 25,700 shares of ANNX stock, worth $144,691. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,700Holding current value
$144,691% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ANNX
# of Institutions
140Shares Held
87.5MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$49 Million9.43% of portfolio
-
Satter Management Co., L.P.7.41MShares$41.7 Million59.29% of portfolio
-
Bvf Inc San Francisco, CA7MShares$39.4 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$31 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$29 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $268M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...